Peter A Kiener Cue Biopharma, Inc. (CUE) insider trading activity

CUE Quotes by TradingView

Peter A Kiener is of Cue Biopharma, Inc.. Currently has a direct ownership of 357 shares of CUE, which is worth approximately $371. The most recent transaction as insider was on Mar 23, 2023, when has been sold 9,325 shares (Common Stock) at a price of $3.28 per share, resulting in proceeds of $30,585. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 357
0% 3M change
0% 12M change
Total Value Held $371

Peter A Kiener Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 23 2023
SELL
Open market or private sale
$30,585 $3.28 p/Share
9,325 Reduced 96.31%
357 Common Stock
Mar 23 2023
BUY
Exercise of conversion of derivative security
$27,690 $2.86 p/Share
9,682 Added 50.0%
9,682 Common Stock
Nov 16 2021
SELL
Open market or private sale
$24,525 $18.02 p/Share
1,361 Reduced 100.0%
0 Common Stock
Nov 16 2021
BUY
Exercise of conversion of derivative security
$3,892 $2.86 p/Share
1,361 Added 50.0%
1,361 Common Stock
Nov 15 2021
SELL
Open market or private sale
$337,165 $17.92 p/Share
18,815 Reduced 100.0%
0 Common Stock
Nov 15 2021
BUY
Exercise of conversion of derivative security
$53,811 $2.86 p/Share
18,815 Added 50.0%
18,815 Common Stock

Also insider at

PIRS
PIERIS PHARMACEUTICALS, INC. Healthcare
Director
PAK

Peter A Kiener

Cambridge, MA

Track Institutional and Insider Activities on CUE

Follow Cue Biopharma, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CUE shares.

Notify only if

Insider Trading

Get notified when an Cue Biopharma, Inc. insider buys or sells CUE shares.

Notify only if

News

Receive news related to Cue Biopharma, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CUE